메뉴 건너뛰기




Volumn 9, Issue 8, 2015, Pages 1039-1053

Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives

Author keywords

liver fibrosis; NAFLD; NASH; Non invasive diagnosis; steatosis; transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKERATIN 18; MICRORNA; MICRORNA 122; BIOLOGICAL MARKER;

EID: 84937559180     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2015.1049155     Document Type: Review
Times cited : (17)

References (123)
  • 1
    • 84861591910 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
    • Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592-609
    • (2012) Gastroenterology , vol.142 , pp. 1592-1609
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3
  • 2
    • 77952576769 scopus 로고    scopus 로고
    • Epidemiology of non-alcoholic fatty liver disease
    • Bellentani S, Scaglioni F, Marino M, et al. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010;28:155-61
    • (2010) Dig Dis , vol.28 , pp. 155-161
    • Bellentani, S.1    Scaglioni, F.2    Marino, M.3
  • 3
    • 21344449292 scopus 로고    scopus 로고
    • Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study
    • Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005;42:44-52
    • (2005) Hepatology , vol.42 , pp. 44-52
    • Bedogni, G.1    Miglioli, L.2    Masutti, F.3
  • 4
    • 33746700131 scopus 로고    scopus 로고
    • Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures
    • Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, et al. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006;26:856-63
    • (2006) Liver Int , vol.26 , pp. 856-863
    • Zelber-Sagi, S.1    Nitzan-Kaluski, D.2    Halpern, Z.3
  • 5
    • 49849087685 scopus 로고    scopus 로고
    • Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection
    • Shi JP, Fan JG, Wu R, et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol 2008;23:1419-25
    • (2008) J Gastroenterol Hepatol , vol.23 , pp. 1419-1425
    • Shi, J.P.1    Fan, J.G.2    Wu, R.3
  • 6
    • 33747047274 scopus 로고    scopus 로고
    • Statins and hepatic steatosis: Perspectives from the Dallas Heart Study
    • Browning JD. Statins and hepatic steatosis: perspectives from the Dallas Heart Study. Hepatology 2006;44:466-71
    • (2006) Hepatology , vol.44 , pp. 466-471
    • Browning, J.D.1
  • 7
    • 80053581540 scopus 로고    scopus 로고
    • Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
    • Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011;141:1249-53
    • (2011) Gastroenterology , vol.141 , pp. 1249-1253
    • Charlton, M.R.1    Burns, J.M.2    Pedersen, R.A.3
  • 8
    • 53549112749 scopus 로고    scopus 로고
    • Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: Causal effect or epiphenomenon?
    • Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008;51: 1947-53
    • (2008) Diabetologia , vol.51 , pp. 1947-1953
    • Targher, G.1    Marra, F.2    Marchesini, G.3
  • 9
    • 24044476188 scopus 로고    scopus 로고
    • Sonographic fatty liver, overweight and ischemic heart disease
    • Lin YC, Lo HM, Chen JD. Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol 2005;11: 4838-42
    • (2005) World J Gastroenterol , vol.11 , pp. 4838-4842
    • Lin, Y.C.1    Lo, H.M.2    Chen, J.D.3
  • 10
    • 77957375969 scopus 로고    scopus 로고
    • Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
    • Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-50
    • (2010) N Engl J Med , vol.363 , pp. 1341-1350
    • Targher, G.1    Day, C.P.2    Bonora, E.3
  • 11
    • 75449088414 scopus 로고    scopus 로고
    • Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
    • Soderberg C, Stal P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010;51:595-602
    • (2010) Hepatology , vol.51 , pp. 595-602
    • Soderberg, C.1    Stal, P.2    Askling, J.3
  • 13
    • 84902546574 scopus 로고    scopus 로고
    • World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    • LaBrecque DR, Abbas Z, Anania F, et al. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 2014;48:467-73
    • (2014) J Clin Gastroenterol , vol.48 , pp. 467-473
    • Labrecque, D.R.1    Abbas, Z.2    Anania, F.3
  • 15
    • 34548337060 scopus 로고    scopus 로고
    • Histological progression of non-alcoholic fatty liver disease: A critical reassessment based on liver sampling variability
    • Ratziu V, Bugianesi E, Dixon J, et al. Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. Aliment Pharmacol Ther 2007;26:821-30
    • (2007) Aliment Pharmacol Ther , vol.26 , pp. 821-830
    • Ratziu, V.1    Bugianesi, E.2    Dixon, J.3
  • 16
    • 29144492550 scopus 로고    scopus 로고
    • Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis
    • Fukusato T, Fukushima J, Shiga J, et al. Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis. Hepatol Res 2005;33:122-7
    • (2005) Hepatol Res , vol.33 , pp. 122-127
    • Fukusato, T.1    Fukushima, J.2    Shiga, J.3
  • 17
    • 33750617920 scopus 로고    scopus 로고
    • Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
    • Merriman RB, Ferrell LD, Patti MG, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006;44:874-80
    • (2006) Hepatology , vol.44 , pp. 874-880
    • Merriman, R.B.1    Ferrell, L.D.2    Patti, M.G.3
  • 18
    • 30044437451 scopus 로고    scopus 로고
    • The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
    • Poynard T, Ratziu V, Naveau S, et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005;4:10
    • (2005) Comp Hepatol , vol.4 , pp. 10
    • Poynard, T.1    Ratziu, V.2    Naveau, S.3
  • 19
    • 33751246499 scopus 로고    scopus 로고
    • The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population
    • Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006;6:33
    • (2006) BMC Gastroenterol , vol.6 , pp. 33
    • Bedogni, G.1    Bellentani, S.2    Miglioli, L.3
  • 20
    • 69249087403 scopus 로고    scopus 로고
    • Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors
    • Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009;137: 865-72
    • (2009) Gastroenterology , vol.137 , pp. 865-872
    • Kotronen, A.1    Peltonen, M.2    Hakkarainen, A.3
  • 21
    • 12344267742 scopus 로고    scopus 로고
    • Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C
    • Poynard T, Imbert-Bismut F, Munteanu M, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004;3:8
    • (2004) Comp Hepatol , vol.3 , pp. 8
    • Poynard, T.1    Imbert-Bismut, F.2    Munteanu, M.3
  • 22
    • 10744221863 scopus 로고    scopus 로고
    • Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B
    • Myers RP, Tainturier MH, Ratziu V, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003;39: 222-30
    • (2003) J Hepatol , vol.39 , pp. 222-230
    • Myers, R.P.1    Tainturier, M.H.2    Ratziu, V.3
  • 23
    • 12344335496 scopus 로고    scopus 로고
    • Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease
    • Naveau S, Raynard B, Ratziu V, et al. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 2005;3:167-74
    • (2005) Clin Gastroenterol Hepatol , vol.3 , pp. 167-174
    • Naveau, S.1    Raynard, B.2    Ratziu, V.3
  • 24
    • 79955606951 scopus 로고    scopus 로고
    • Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity
    • Lassailly G, Caiazzo R, Hollebecque A, et al. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. Eur J Gastroenterol Hepatol 2011;23:499-506
    • (2011) Eur J Gastroenterol Hepatol , vol.23 , pp. 499-506
    • Lassailly, G.1    Caiazzo, R.2    Hollebecque, A.3
  • 25
    • 84858224449 scopus 로고    scopus 로고
    • Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: Meta analysis of individual patient data
    • Poynard T, Lassailly G, Diaz E, et al. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS ONE 2012;7: e30325
    • (2012) PLoS ONE , vol.7 , pp. e30325
    • Poynard, T.1    Lassailly, G.2    Diaz, E.3
  • 26
    • 66149119340 scopus 로고    scopus 로고
    • Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population
    • Gastaldelli A, Kozakova M, Hjlund K, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009;49:1537-44
    • (2009) Hepatology , vol.49 , pp. 1537-1544
    • Gastaldelli, A.1    Kozakova, M.2    Hjlund, K.3
  • 27
    • 77953045389 scopus 로고    scopus 로고
    • Nine-year incident diabetes is predicted by fatty liver indices: The French D.E.S.I.R. Study
    • Balkau B, Lange C, Vol S, et al. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 2010;10:56
    • (2010) BMC Gastroenterol , vol.10 , pp. 56
    • Balkau, B.1    Lange, C.2    Vol, S.3
  • 28
    • 77955828718 scopus 로고    scopus 로고
    • A simple index of lipid overaccumulation is a good marker of liver steatosis
    • Bedogni G, Kahn HS, Bellentani S, et al. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 2010;10:98
    • (2010) BMC Gastroenterol , vol.10 , pp. 98
    • Bedogni, G.1    Kahn, H.S.2    Bellentani, S.3
  • 29
    • 26844479095 scopus 로고    scopus 로고
    • The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison
    • Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005;5:26
    • (2005) BMC Cardiovasc Disord , vol.5 , pp. 26
    • Kahn, H.S.1
  • 30
    • 33644876260 scopus 로고    scopus 로고
    • The lipid accumulation product is better than BMI for identifying diabetes: A population-based comparison
    • Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care 2006;29:151-3
    • (2006) Diabetes Care , vol.29 , pp. 151-153
    • Kahn, H.S.1
  • 31
    • 77956095443 scopus 로고    scopus 로고
    • The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: A PreCIS database study
    • Ioachimescu AG, Brennan DM, Hoar BM, et al. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring) 2010;18:1836-44
    • (2010) Obesity (Silver Spring , vol.18 , pp. 1836-1844
    • Ioachimescu, A.G.1    Brennan, D.M.2    Hoar, B.M.3
  • 32
    • 84937602741 scopus 로고    scopus 로고
    • International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome
    • International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome
  • 33
    • 0022645750 scopus 로고
    • Ultrasound scanning in the detection of hepatic fibrosis and steatosis
    • Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986;292:13-15
    • (1986) Br Med J (Clin Res Ed , vol.292 , pp. 13-15
    • Saverymuttu, S.H.1    Joseph, A.E.2    Maxwell, J.D.3
  • 34
    • 12944284724 scopus 로고    scopus 로고
    • Quantitative estimation of attenuation in ultrasound video images: Correlation with histology in diffuse liver disease
    • Graif M, Yanuka M, Baraz M, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000;35:319-24
    • (2000) Invest Radiol , vol.35 , pp. 319-324
    • Graif, M.1    Yanuka, M.2    Baraz, M.3
  • 35
    • 33748498921 scopus 로고    scopus 로고
    • The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis
    • Palmentieri B, de Sio I, La Mura V, et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006;38:485-9
    • (2006) Dig Liver Dis , vol.38 , pp. 485-489
    • Palmentieri, B.1    De Sio, I.2    La Mura, V.3
  • 36
    • 68049120181 scopus 로고    scopus 로고
    • Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance
    • Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51: 433-45
    • (2009) J Hepatol , vol.51 , pp. 433-445
    • Schwenzer, N.F.1    Springer, F.2    Schraml, C.3
  • 37
    • 36448976537 scopus 로고    scopus 로고
    • Interobserver and intraobserver variability in the sonographic assessment of fatty liver
    • Strauss S, Gavish E, Gottlieb P, et al. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 2007;189:W320-3
    • (2007) AJR Am J Roentgenol , vol.189 , pp. W320-W323
    • Strauss, S.1    Gavish, E.2    Gottlieb, P.3
  • 38
    • 84865191383 scopus 로고    scopus 로고
    • Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD
    • Ballestri S, Lonardo A, Romagnoli D, et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int 2012;32:1242-52
    • (2012) Liver Int , vol.32 , pp. 1242-1252
    • Ballestri, S.1    Lonardo, A.2    Romagnoli, D.3
  • 39
    • 36549056996 scopus 로고    scopus 로고
    • The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation
    • Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007;102:2708-15
    • (2007) Am J Gastroenterol , vol.102 , pp. 2708-2715
    • Hamaguchi, M.1    Kojima, T.2    Itoh, Y.3
  • 40
    • 77956572465 scopus 로고    scopus 로고
    • Correlation of hepatic vein Doppler waveform and hepatic artery resistance index with the severity of nonalcoholic fatty liver disease
    • Mohammadinia AR, Bakhtavar K, Ebrahimi-Daryani N, et al. Correlation of hepatic vein Doppler waveform and hepatic artery resistance index with the severity of nonalcoholic fatty liver disease. J Clin Ultrasound 2010;38:346-52
    • (2010) J Clin Ultrasound , vol.38 , pp. 346-352
    • Mohammadinia, A.R.1    Bakhtavar, K.2    Ebrahimi-Daryani, N.3
  • 41
    • 84856708238 scopus 로고    scopus 로고
    • The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan
    • Sasso M, Miette V, Sandrin L, et al. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol 2012;36:13-20
    • (2012) Clin Res Hepatol Gastroenterol , vol.36 , pp. 13-20
    • Sasso, M.1    Miette, V.2    Sandrin, L.3
  • 42
    • 77958154016 scopus 로고    scopus 로고
    • Controlled attenuation parameter (CAP): A novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes
    • Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010;36:1825-35
    • (2010) Ultrasound Med Biol , vol.36 , pp. 1825-1835
    • Sasso, M.1    Beaugrand, M.2    De Ledinghen, V.3
  • 43
    • 84861981022 scopus 로고    scopus 로고
    • Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography
    • de Ledinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 2012;32:911-18
    • (2012) Liver Int , vol.32 , pp. 911-918
    • De Ledinghen, V.1    Vergniol, J.2    Foucher, J.3
  • 44
    • 84861961483 scopus 로고    scopus 로고
    • Controlled Attenuation Parameter (CAP): A noninvasive method for the detection of hepatic steatosis based on transient elastography
    • Myers RP, Pollett A, Kirsch R, et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 2012;32:902-10
    • (2012) Liver Int , vol.32 , pp. 902-910
    • Myers, R.P.1    Pollett, A.2    Kirsch, R.3
  • 45
    • 84898827951 scopus 로고    scopus 로고
    • Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations
    • de Ledinghen V, Vergniol J, Capdepont M, et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol 2014;60:1026-31
    • (2014) J Hepatol , vol.60 , pp. 1026-1031
    • De Ledinghen, V.1    Vergniol, J.2    Capdepont, M.3
  • 46
    • 33645112815 scopus 로고    scopus 로고
    • Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment
    • Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006;239: 105-12
    • (2006) Radiology , vol.239 , pp. 105-112
    • Park, S.H.1    Kim, P.N.2    Kim, K.W.3
  • 47
    • 53549134421 scopus 로고    scopus 로고
    • Magnetic resonance imaging and spectroscopy for monitoring liver steatosis
    • Cowin GJ, Jonsson JR, Bauer JD, et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 2008;28:937-45
    • (2008) J Magn Reson Imaging , vol.28 , pp. 937-945
    • Cowin, G.J.1    Jonsson, J.R.2    Bauer, J.D.3
  • 48
    • 12144259379 scopus 로고    scopus 로고
    • Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population
    • Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2008;288:E462-8
    • (2008) Am J Physiol Endocrinol Metab , vol.288 , pp. E462-E468
    • Szczepaniak, L.S.1    Nurenberg, P.2    Leonard, D.3
  • 49
    • 84876907610 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis
    • Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267:422-31
    • (2013) Radiology , vol.267 , pp. 422-431
    • Tang, A.1    Tan, J.2    Sun, M.3
  • 50
    • 77953925097 scopus 로고    scopus 로고
    • Assessment of hepatic steatosis in patients undergoing liver resection: Comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy
    • van Werven JR, Marsman HA, Nederveen AJ, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 2010;256:159-68
    • (2010) Radiology , vol.256 , pp. 159-168
    • Van Werven, J.R.1    Marsman, H.A.2    Nederveen, A.J.3
  • 51
    • 67649205135 scopus 로고    scopus 로고
    • Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered
    • McPherson S, Jonsson JR, Cowin GJ, et al. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 2009;51:389-97
    • (2009) J Hepatol , vol.51 , pp. 389-397
    • McPherson, S.1    Jonsson, J.R.2    Cowin, G.J.3
  • 52
    • 0033200054 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
    • Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74
    • (1999) Am J Gastroenterol , vol.94 , pp. 2467-2474
    • Brunt, E.M.1    Janney, C.G.2    Di Bisceglie, A.M.3
  • 53
    • 20044374023 scopus 로고    scopus 로고
    • Design and validation of a histological scoring system for nonalcoholic fatty liver disease
    • Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21
    • (2005) Hepatology , vol.41 , pp. 1313-1321
    • Kleiner, D.E.1    Brunt, E.M.2    Van Natta, M.3
  • 54
    • 51349083814 scopus 로고    scopus 로고
    • Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
    • Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 2008;48:792-8
    • (2008) Hepatology , vol.48 , pp. 792-798
    • Fracanzani, A.L.1    Valenti, L.2    Bugianesi, E.3
  • 55
    • 33845207096 scopus 로고    scopus 로고
    • Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease
    • Poynard T, Ratziu V, Charlotte F, et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006;6:34
    • (2006) BMC Gastroenterol , vol.6 , pp. 34
    • Poynard, T.1    Ratziu, V.2    Charlotte, F.3
  • 56
    • 33646013904 scopus 로고    scopus 로고
    • Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease
    • Palekar NA, Naus R, Larson SP, et al. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. Liver Int 2006;26:151-6
    • (2006) Liver Int , vol.26 , pp. 151-156
    • Palekar, N.A.1    Naus, R.2    Larson, S.P.3
  • 57
    • 34547539428 scopus 로고    scopus 로고
    • Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis
    • Shimada M, Kawahara H, Ozaki K, et al. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. Am J Gastroenterol 2007;102:1931-8
    • (2007) Am J Gastroenterol , vol.102 , pp. 1931-1938
    • Shimada, M.1    Kawahara, H.2    Ozaki, K.3
  • 58
    • 70350046669 scopus 로고    scopus 로고
    • Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
    • Feldstein AE, Wieckowska A, Lopez AR, et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009;50:1072-8
    • (2009) Hepatology , vol.50 , pp. 1072-1078
    • Feldstein, A.E.1    Wieckowska, A.2    Lopez, A.R.3
  • 59
    • 79956108335 scopus 로고    scopus 로고
    • An apoptosis panel for nonalcoholic steatohepatitis diagnosis
    • Tamimi TI, Elgouhari HM, Alkhouri N, et al. An apoptosis panel for nonalcoholic steatohepatitis diagnosis. J Hepatol 2011;54: 1224-9
    • (2011) J Hepatol , vol.54 , pp. 1224-1229
    • Tamimi, T.I.1    Elgouhari, H.M.2    Alkhouri, N.3
  • 60
    • 79955764437 scopus 로고    scopus 로고
    • A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis
    • Younossi ZM, Page S, Rafiq N, et al. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis. Obes Surg 2011;21:431-9
    • (2011) Obes Surg , vol.21 , pp. 431-439
    • Younossi, Z.M.1    Page, S.2    Rafiq, N.3
  • 61
    • 77956822767 scopus 로고    scopus 로고
    • Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    • Feldstein AE, Lopez R, Tamimi TA, et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Lipid Res 2010;51:3046-54
    • (2010) J Lipid Res , vol.51 , pp. 3046-3054
    • Feldstein, A.E.1    Lopez, R.2    Tamimi, T.A.3
  • 62
    • 33745904468 scopus 로고    scopus 로고
    • In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
    • Wieckowska A, Zein NN, Yerian LM, et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006;44:27-33
    • (2006) Hepatology , vol.44 , pp. 27-33
    • Wieckowska, A.1    Zein, N.N.2    Yerian, L.M.3
  • 63
    • 33947528311 scopus 로고    scopus 로고
    • Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
    • Yilmaz Y, Dolar E, Ulukaya E, et al. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007;13:837-44
    • (2007) World J Gastroenterol , vol.13 , pp. 837-844
    • Yilmaz, Y.1    Dolar, E.2    Ulukaya, E.3
  • 64
    • 55149102644 scopus 로고    scopus 로고
    • Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients
    • Diab DL, Yerian L, Schauer P, et al. Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin Gastroenterol Hepatol 2008;6:1249-54
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 1249-1254
    • Diab, D.L.1    Yerian, L.2    Schauer, P.3
  • 65
    • 84856388968 scopus 로고    scopus 로고
    • Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis
    • Joka D, Wahl K, Moeller S, et al. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology 2012;55:455-64
    • (2012) Hepatology , vol.55 , pp. 455-464
    • Joka, D.1    Wahl, K.2    Moeller, S.3
  • 66
    • 84890547086 scopus 로고    scopus 로고
    • Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
    • Cusi K, Chang Z, Harrison S, et al. Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol 2014;60:167-74
    • (2014) J Hepatol , vol.60 , pp. 167-174
    • Cusi, K.1    Chang, Z.2    Harrison, S.3
  • 67
    • 84903544714 scopus 로고    scopus 로고
    • OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease
    • Alkhouri N, Berk M, Yerian L, et al. OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease. Dig Dis Sci 2014;59:1617-24
    • (2014) Dig Dis Sci , vol.59 , pp. 1617-1624
    • Alkhouri, N.1    Berk, M.2    Yerian, L.3
  • 68
    • 84897505627 scopus 로고    scopus 로고
    • MicroRNAs in nonalcoholic fatty liver disease: Novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma
    • Gori M, Arciello M, Balsano C. MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. Biomed Res Int 2014;741465
    • (2014) Biomed Res Int , pp. 741465
    • Gori, M.1    Arciello, M.2    Balsano, C.3
  • 69
    • 80052008851 scopus 로고    scopus 로고
    • Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease
    • Cermelli S, Ruggieri A, Marrero JA, et al. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE 2011;6:e23937
    • (2011) PLoS ONE , vol.6 , pp. e23937
    • Cermelli, S.1    Ruggieri, A.2    Marrero, J.A.3
  • 70
    • 84879448114 scopus 로고    scopus 로고
    • Associations between circulating microRNAs (MIR-21, MIR-34a, MIR-122 and MIR-451) and non-alcoholic fatty liver
    • Yamada H, Suzuki K, Ichino N, et al. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta 2013;424:99-103
    • (2013) Clin Chim Acta , vol.424 , pp. 99-103
    • Yamada, H.1    Suzuki, K.2    Ichino, N.3
  • 71
    • 78650926757 scopus 로고    scopus 로고
    • Which clinical and sonographic parameters may be useful to discriminate NASH from steatosis?
    • Zardi EM, De Sio I, Ghittoni G, et al. Which clinical and sonographic parameters may be useful to discriminate NASH from steatosis? J Clin Gastroenterol 2011;45: 59-63
    • (2011) J Clin Gastroenterol , vol.45 , pp. 59-63
    • Zardi, E.M.1    De Sio, I.2    Ghittoni, G.3
  • 72
    • 79956292596 scopus 로고    scopus 로고
    • Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography
    • Chen J, Talwalkar JA, Yin M, et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011;259:749-56
    • (2011) Radiology , vol.259 , pp. 749-756
    • Chen, J.1    Talwalkar, J.A.2    Yin, M.3
  • 73
    • 84911948591 scopus 로고    scopus 로고
    • Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
    • Loomba R, Wolfson T, Ang B, et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology 2014;60:1920-8
    • (2014) Hepatology , vol.60 , pp. 1920-8
    • Loomba, R.1    Wolfson, T.2    Ang, B.3
  • 74
    • 41849148981 scopus 로고    scopus 로고
    • Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD
    • Yoneda M, Mawatari H, Fujita K, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40:371-8
    • (2008) Dig Liver Dis , vol.40 , pp. 371-378
    • Yoneda, M.1    Mawatari, H.2    Fujita, K.3
  • 75
    • 84860389114 scopus 로고    scopus 로고
    • Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease
    • Palmeri ML, Wang MH, Rouze NC, et al. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol 2011;55:666-72
    • (2011) J Hepatol , vol.55 , pp. 666-672
    • Palmeri, M.L.1    Wang, M.H.2    Rouze, N.C.3
  • 76
    • 79957521377 scopus 로고    scopus 로고
    • Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
    • Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011;53:1874-82
    • (2011) Hepatology , vol.53 , pp. 1874-1882
    • Younossi, Z.M.1    Stepanova, M.2    Rafiq, N.3
  • 77
    • 79957504753 scopus 로고    scopus 로고
    • Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: Two distinct concepts
    • Angulo P. Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology 2011;53:1792-4
    • (2011) Hepatology , vol.53 , pp. 1792-1794
    • Angulo, P.1
  • 78
    • 0032695030 scopus 로고    scopus 로고
    • Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
    • Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62
    • (1999) Hepatology , vol.30 , pp. 1356-1362
    • Angulo, P.1    Keach, J.C.2    Batts, K.P.3
  • 79
    • 0036903644 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis: Risk factors for liver fibrosis
    • Shimada M, Hashimoto E, Kaneda H, et al. Nonalcoholic steatohepatitis: risk factors for liver fibrosis. Hepatol Res 2002;24:429-38
    • (2002) Hepatol Res , vol.24 , pp. 429-438
    • Shimada, M.1    Hashimoto, E.2    Kaneda, H.3
  • 80
    • 79952479754 scopus 로고    scopus 로고
    • Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease
    • Yilmaz Y, Yonal O, Kurt R, et al. Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease. Hepat Mon 2011;11:103-6
    • (2011) Hepat Mon , vol.11 , pp. 103-106
    • Yilmaz, Y.1    Yonal, O.2    Kurt, R.3
  • 81
    • 79960979728 scopus 로고    scopus 로고
    • APRI: A simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH
    • Kruger FC, Daniels CR, Kidd M, et al. APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. S Afr Med J 2011;101:477-80
    • (2011) S Afr Med J , vol.101 , pp. 477-480
    • Kruger, F.C.1    Daniels, C.R.2    Kidd, M.3
  • 82
    • 22844448952 scopus 로고    scopus 로고
    • Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease
    • Suzuki A, Angulo P, Lymp J, et al. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int 2005;25:779-86
    • (2005) Liver Int , vol.25 , pp. 779-786
    • Suzuki, A.1    Angulo, P.2    Lymp, J.3
  • 83
    • 34447519882 scopus 로고    scopus 로고
    • Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage
    • Yoneda M, Mawatari H, Fujita K, et al. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J Gastroenterol 2007;42:375-81
    • (2007) J Gastroenterol , vol.42 , pp. 375-381
    • Yoneda, M.1    Mawatari, H.2    Fujita, K.3
  • 84
    • 68149182338 scopus 로고    scopus 로고
    • Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis
    • Lesmana CR, Hasan I, Budihusodo U, et al. Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis. J Dig Dis 2009;10:201-6
    • (2009) J Dig Dis , vol.10 , pp. 201-206
    • Lesmana, C.R.1    Hasan, I.2    Budihusodo, U.3
  • 85
    • 77956119396 scopus 로고    scopus 로고
    • Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
    • McPherson S, Stewart SF, Henderson E, et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 2010;59:1265-9
    • (2010) Gut , vol.59 , pp. 1265-1269
    • McPherson, S.1    Stewart, S.F.2    Henderson, E.3
  • 86
    • 33644607568 scopus 로고    scopus 로고
    • Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
    • Ratziu V, Massard J, Charlotte F, et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006;6:6
    • (2006) BMC Gastroenterol , vol.6 , pp. 6
    • Ratziu, V.1    Massard, J.2    Charlotte, F.3
  • 87
    • 34247384560 scopus 로고    scopus 로고
    • The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
    • Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007;45: 846-54
    • (2007) Hepatology , vol.45 , pp. 846-854
    • Angulo, P.1    Hui, J.M.2    Marchesini, G.3
  • 88
    • 39549118158 scopus 로고    scopus 로고
    • Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
    • Guha IN, Parkes J, Roderick P, et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008;47:455-60
    • (2008) Hepatology , vol.47 , pp. 455-460
    • Guha, I.N.1    Parkes, J.2    Roderick, P.3
  • 89
    • 56949084285 scopus 로고    scopus 로고
    • Comparison of blood tests for liver fibrosis specific or not to NAFLD
    • Cales P, Laine F, Boursier J, et al. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol 2009;50:165-73
    • (2009) J Hepatol , vol.50 , pp. 165-173
    • Cales, P.1    Laine, F.2    Boursier, J.3
  • 90
    • 52649112178 scopus 로고    scopus 로고
    • Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
    • Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008;57:1441-7
    • (2008) Gut , vol.57 , pp. 1441-1447
    • Harrison, S.A.1    Oliver, D.2    Arnold, H.L.3
  • 91
    • 80053095798 scopus 로고    scopus 로고
    • Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease
    • Adams LA, George J, Bugianesi E, et al. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011;26:1536-43
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 1536-1543
    • Adams, L.A.1    George, J.2    Bugianesi, E.3
  • 92
    • 33846015006 scopus 로고    scopus 로고
    • Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia
    • Ratziu V, Giral P, Munteanu M, et al. Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia. Aliment Pharmacol Ther 2007;25:207-18
    • (2007) Aliment Pharmacol Ther , vol.25 , pp. 207-218
    • Ratziu, V.1    Giral, P.2    Munteanu, M.3
  • 93
    • 45949105157 scopus 로고    scopus 로고
    • Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes
    • Jacqueminet S, Lebray P, Morra R, et al. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol 2008;6:828-31
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 828-831
    • Jacqueminet, S.1    Lebray, P.2    Morra, R.3
  • 94
    • 84865134394 scopus 로고    scopus 로고
    • Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population
    • Poynard T, Munteanu M, Deckmyn O, et al. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population. J Hepatol 2012;57:541-8
    • (2012) J Hepatol , vol.57 , pp. 541-548
    • Poynard, T.1    Munteanu, M.2    Deckmyn, O.3
  • 95
    • 84868119124 scopus 로고    scopus 로고
    • Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease
    • Xun YH, Fan JG, Zang GQ, et al. Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. J Dig Dis 2012;13:588-95
    • (2012) J Dig Dis , vol.13 , pp. 588-595
    • Xun, Y.H.1    Fan, J.G.2    Zang, G.Q.3
  • 96
    • 70349546276 scopus 로고    scopus 로고
    • Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease
    • Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7:1104-12
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 1104-1112
    • Shah, A.G.1    Lydecker, A.2    Murray, K.3
  • 97
    • 80555136061 scopus 로고    scopus 로고
    • Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
    • Musso G, Gambino R, Cassader M, et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43: 617-49
    • (2011) Ann Med , vol.43 , pp. 617-649
    • Musso, G.1    Gambino, R.2    Cassader, M.3
  • 98
    • 50649109837 scopus 로고    scopus 로고
    • Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis
    • Wong VW, Wong GL, Chim AM, et al. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am J Gastroenterol 2008;103:1682-8
    • (2008) Am J Gastroenterol , vol.103 , pp. 1682-1688
    • Wong, V.W.1    Wong, G.L.2    Chim, A.M.3
  • 99
    • 84911177289 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD
    • Xun YH, Guo JC, Lou GQ, et al. Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD. Clin Exp Pharmacol Physiol 2014;41:643-9
    • (2014) Clin Exp Pharmacol Physiol , vol.41 , pp. 643-649
    • Xun, Y.H.1    Guo, J.C.2    Lou, G.Q.3
  • 100
    • 84884416525 scopus 로고    scopus 로고
    • Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease
    • Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013;145:782-89.e784
    • (2013) Gastroenterology , vol.145 , pp. 782-89e784
    • Angulo, P.1    Bugianesi, E.2    Bjornsson, E.S.3
  • 101
    • 84885776637 scopus 로고    scopus 로고
    • Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population
    • Perez-Gutierrez OZ, Hernandez-Rocha C, Candia-Balboa RA, et al. Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population. Ann Hepatol 2013;12: 416-24
    • (2013) Ann Hepatol , vol.12 , pp. 416-424
    • Perez-Gutierrez, O.Z.1    Hernandez-Rocha, C.2    Candia-Balboa, R.A.3
  • 102
    • 84944511823 scopus 로고    scopus 로고
    • A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis
    • [Epub ahead of print]
    • Chan WK, Nik Mustapha NR, Mahadeva S. A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Hepatol Int 2014. [Epub ahead of print]
    • (2014) Hepatol Int
    • Chan, W.K.1    Nik Mustapha, N.R.2    Mahadeva, S.3
  • 103
    • 34548124999 scopus 로고    scopus 로고
    • Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD
    • Yoneda M, Fujita K, Inamori M, et al. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007;56:1330-1
    • (2007) Gut , vol.56 , pp. 1330-1331
    • Yoneda, M.1    Fujita, K.2    Inamori, M.3
  • 104
    • 75449091784 scopus 로고    scopus 로고
    • Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
    • Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010;51: 454-62
    • (2010) Hepatology , vol.51 , pp. 454-462
    • Wong, V.W.1    Vergniol, J.2    Wong, G.L.3
  • 105
    • 77951161889 scopus 로고    scopus 로고
    • Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis
    • Lupsor M, Badea R, Stefanescu H, et al. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis 2010;19:53-60
    • (2010) J Gastrointestin Liver Dis , vol.19 , pp. 53-60
    • Lupsor, M.1    Badea, R.2    Stefanescu, H.3
  • 106
    • 84873194955 scopus 로고    scopus 로고
    • Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: Diagnostic performance and clinicopathological correlation
    • Kumar R, Rastogi A, Sharma MK, et al. Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. Dig Dis Sci 2013;58:265-74
    • (2013) Dig Dis Sci , vol.58 , pp. 265-274
    • Kumar, R.1    Rastogi, A.2    Sharma, M.K.3
  • 107
    • 79956094278 scopus 로고    scopus 로고
    • Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: The effects of body mass index
    • Petta S, Di Marco V, Camma C, et al. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 2011;33:1350-60
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 1350-1360
    • Petta, S.1    Di Marco, V.2    Camma, C.3
  • 108
    • 78751566170 scopus 로고    scopus 로고
    • Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy
    • Myers RP, Crotty P, Pomier-Layrargues G, et al. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 2010;30:1471-80
    • (2010) Liver Int , vol.30 , pp. 1471-1480
    • Myers, R.P.1    Crotty, P.2    Pomier-Layrargues, G.3
  • 109
    • 77956015752 scopus 로고    scopus 로고
    • Feasibility of liver transient elastography with FibroScan using a new probe for obese patients
    • de Ledinghen V, Vergniol J, Foucher J, et al. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int 2010;30: 1043-8
    • (2010) Liver Int , vol.30 , pp. 1043-1048
    • De Ledinghen, V.1    Vergniol, J.2    Foucher, J.3
  • 110
    • 84155188892 scopus 로고    scopus 로고
    • Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
    • Myers RP, Pomier-Layrargues G, Kirsch R, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012;55:199-208
    • (2012) Hepatology , vol.55 , pp. 199-208
    • Myers, R.P.1    Pomier-Layrargues, G.2    Kirsch, R.3
  • 111
    • 84870819164 scopus 로고    scopus 로고
    • Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease
    • Wong VW, Vergniol J, Wong GL, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012;107: 1862-71
    • (2012) Am J Gastroenterol , vol.107 , pp. 1862-1871
    • Wong, V.W.1    Vergniol, J.2    Wong, G.L.3
  • 112
    • 84857369747 scopus 로고    scopus 로고
    • Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe
    • Myers RP, Pomier-Layrargues G, Kirsch R, et al. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 2012;56:564-70
    • (2012) J Hepatol , vol.56 , pp. 564-570
    • Myers, R.P.1    Pomier-Layrargues, G.2    Kirsch, R.3
  • 113
    • 84937538751 scopus 로고    scopus 로고
    • The Diagnostic Accuracy of Transient Elastography for the Diagnosis of Liver Fibrosis in Bariatric Surgery Candidates with Suspected NAFLD
    • Naveau S, Lamouri K, Pourcher G, et al. The Diagnostic Accuracy of Transient Elastography for the Diagnosis of Liver Fibrosis in Bariatric Surgery Candidates with Suspected NAFLD. Obes Surg 2010;24:1693-701
    • (2010) Obes Surg , vol.24 , pp. 1693-1701
    • Naveau, S.1    Lamouri, K.2    Pourcher, G.3
  • 114
    • 85027943357 scopus 로고    scopus 로고
    • Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: Comparison with Fibroscan
    • Ebinuma H, Saito H, Komuta M, et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan(-). J Gastroenterol 2011;46:1238-48
    • (2011) J Gastroenterol , vol.46 , pp. 1238-1248
    • Ebinuma, H.1    Saito, H.2    Komuta, M.3
  • 115
    • 77955147344 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography
    • Yoneda M, Suzuki K, Kato S, et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 2010;256:640-7
    • (2010) Radiology , vol.256 , pp. 640-647
    • Yoneda, M.1    Suzuki, K.2    Kato, S.3
  • 116
    • 84856968669 scopus 로고    scopus 로고
    • Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD
    • Friedrich-Rust M, Romen D, Vermehren J, et al. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 2012;81:e325-31
    • (2012) Eur J Radiol , vol.81 , pp. e325-e331
    • Friedrich-Rust, M.1    Romen, D.2    Vermehren, J.3
  • 117
    • 84884532499 scopus 로고    scopus 로고
    • Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease
    • Fierbinteanu Braticevici C, Sporea I, Panaitescu E, et al. Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. Ultrasound Med Biol 2013;39:1942-50
    • (2013) Ultrasound Med Biol , vol.39 , pp. 1942-1950
    • Fierbinteanu Braticevici, C.1    Sporea, I.2    Panaitescu, E.3
  • 118
    • 33847202224 scopus 로고    scopus 로고
    • Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis
    • Friedrich-Rust M, Ong MF, Herrmann E, et al. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 2007;188: 758-64
    • (2007) AJR Am J Roentgenol , vol.188 , pp. 758-764
    • Friedrich-Rust, M.1    Ong, M.F.2    Herrmann, E.3
  • 119
    • 84857800105 scopus 로고    scopus 로고
    • Liver elasticity in NASH patients evaluated with real-time elastography (RTE
    • Orlacchio A, Bolacchi F, Antonicoli M, et al. Liver elasticity in NASH patients evaluated with real-time elastography (RTE). Ultrasound Med Biol 2012;38:537-44
    • (2012) Ultrasound Med Biol , vol.38 , pp. 537-544
    • Orlacchio, A.1    Bolacchi, F.2    Antonicoli, M.3
  • 120
    • 84867220096 scopus 로고    scopus 로고
    • Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases
    • Ochi H, Hirooka M, Koizumi Y, et al. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology 2012;56:1271-8
    • (2012) Hepatology , vol.56 , pp. 1271-1278
    • Ochi, H.1    Hirooka, M.2    Koizumi, Y.3
  • 121
    • 84874226671 scopus 로고    scopus 로고
    • Magnetic resonance elastography of liver: Technique, analysis, and clinical applications
    • Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 2013;37:544-55
    • (2013) J Magn Reson Imaging , vol.37 , pp. 544-555
    • Venkatesh, S.K.1    Yin, M.2    Ehman, R.L.3
  • 122
    • 84880649809 scopus 로고    scopus 로고
    • Advanced fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment with MR elastography
    • Kim D, Kim WR, Talwalkar JA, et al. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology 2013;268:411-19
    • (2013) Radiology , vol.268 , pp. 411-419
    • Kim, D.1    Kim, W.R.2    Talwalkar, J.A.3
  • 123
    • 84861197159 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
    • Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012;56:1384-91
    • (2012) J Hepatol , vol.56 , pp. 1384-1391
    • Baffy, G.1    Brunt, E.M.2    Caldwell, S.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.